Is Laparoscopy-assisted Radical Gastrectomy Safe in Patients with Child-Pugh Class A Cirrhosis?

Sin Jae Kang1, Mi Ran Jung1, Oh Cheong1

  • 1Department of Surgery, Chonnam National University Medical School, Gwangju, Korea.

Journal of Gastric Cancer
|February 11, 2014
PubMed

Insights

Radical gastrectomy for gastric cancer in patients with liver cirrhosis (Child-Pugh class A) showed no postoperative mortality. Laparoscopic gastrectomy is a safe option for these patients.

Area of Science:

  • Gastroenterology
  • Surgical Oncology
  • Hepatology

Background:

  • Liver cirrhosis poses significant risks for major surgery.
  • Gastric cancer management in cirrhotic patients requires careful consideration of surgical approach.
  • Assessing early postoperative outcomes is crucial for patient selection and surgical planning.

Purpose of the Study:

  • To investigate early postoperative morbidity and mortality in liver cirrhosis patients undergoing radical gastrectomy for gastric cancer.
  • To compare outcomes between open and laparoscopic gastrectomy in this specific patient group.

Main Methods:

  • Retrospective review of 41 Child-Pugh class A patients with liver cirrhosis who underwent radical gastrectomy.
  • Analysis of postoperative complications including ascites, hemorrhage, and wound infection.
  • Statistical correction for confounding factors like cancer stage between open and laparoscopic groups.

Main Results:

  • Overall postoperative complication rate was 53.7%, with ascites being the most common (46.3%).
  • No postoperative mortality was observed in any patient.
  • No statistically significant difference in major complications (ascites, hemorrhage, wound infection, intra-abdominal abscess) between open and laparoscopic gastrectomy after adjusting for cancer stage.

Conclusions:

  • Laparoscopic gastrectomy is a feasible and safe surgical procedure for selected patients with moderate hepatic dysfunction (Child-Pugh class A) undergoing radical gastrectomy for gastric cancer.
  • The findings support the use of minimally invasive approaches in cirrhotic patients when oncologically indicated.
Abstract